Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Jonsson Comprehensive Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00024076 |
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. CT-guided radiofrequency ablation may be effective treatment for lung cancer.
PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have refractory or advanced lung cancer.
Condition | Intervention | Phase |
---|---|---|
Lung Cancer Malignant Mesothelioma Metastatic Cancer Thymoma and Thymic Carcinoma |
Procedure: radiofrequency ablation |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Radiofrequency Ablation of Pulmonary Malignancy |
Study Start Date: | July 2001 |
OBJECTIVES:
OUTLINE: Patients undergo percutaneous CT-guided radiofrequency ablation directly to the tumor over 2 hours.
Patients are followed at 1, 3, 6, and 12 months.
PROJECTED ACCRUAL: A total of 30 patients will be accrued for this study.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of a primary or secondary intrathoracic malignancy
Single or multiple lesions that are non-contiguous with vital structures or organs such as:
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
PRIOR CONCURRENT THERAPY:
United States, California | |
Jonsson Comprehensive Cancer Center, UCLA | |
Los Angeles, California, United States, 90095-1781 |
Study Chair: | Robert D. Suh, MD | Jonsson Comprehensive Cancer Center |
Study ID Numbers: | CDR0000068889, UCLA-9908024, NCI-G01-2011 |
Study First Received: | September 13, 2001 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00024076 History of Changes |
Health Authority: | United States: Federal Government |
recurrent non-small cell lung cancer recurrent small cell lung cancer recurrent malignant mesothelioma recurrent thymoma and thymic carcinoma |
stage IIIB non-small cell lung cancer stage IV non-small cell lung cancer pulmonary carcinoid tumor lung metastases |
Thoracic Neoplasms Recurrence Carcinoma Carcinoma, Small Cell Respiratory Tract Diseases Lung Neoplasms Lung Diseases Thymoma |
Thymus Neoplasms Neoplasm Metastasis Non-small Cell Lung Cancer Mesothelioma Carcinoid Tumor Adenoma Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |
Thoracic Neoplasms Respiratory Tract Neoplasms Neoplasms by Histologic Type Neoplasms, Mesothelial Carcinoma Neoplastic Processes Neoplasms Pathologic Processes Neoplasms by Site Respiratory Tract Diseases |
Lung Neoplasms Lung Diseases Thymoma Thymus Neoplasms Neoplasm Metastasis Mesothelioma Adenoma Neoplasms, Complex and Mixed Neoplasms, Glandular and Epithelial |